Success Metrics

Clinical Success Rate
94.8%

Based on 55 completed trials

Completion Rate
95%(55/58)
Active Trials
14(15%)
Results Posted
29%(16 trials)
Terminated
3(3%)

Phase Distribution

Ph not_applicable
11
11%
Ph phase_1
8
8%
Ph phase_2
27
28%
Ph phase_3
29
30%
Ph phase_4
12
13%
Ph early_phase_1
4
4%

Phase Distribution

12

Early Stage

27

Mid Stage

41

Late Stage

Phase Distribution91 total trials
Early Phase 1First-in-human
4(4.4%)
Phase 1Safety & dosage
8(8.8%)
Phase 2Efficacy & side effects
27(29.7%)
Phase 3Large-scale testing
29(31.9%)
Phase 4Post-market surveillance
12(13.2%)
N/ANon-phased studies
11(12.1%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

90.2%

55 of 61 finished

Non-Completion Rate

9.8%

6 ended early

Currently Active

14

trials recruiting

Total Trials

96

all time

Status Distribution
Active(17)
Completed(55)
Terminated(6)
Other(18)

Detailed Status

Completed55
unknown17
Active, not recruiting8
Recruiting6
Withdrawn3
Not yet recruiting3

Development Timeline

Analytics

Development Status

Total Trials
96
Active
14
Success Rate
94.8%
Most Advanced
Phase 4

Trials by Phase

Early Phase 14 (4.4%)
Phase 18 (8.8%)
Phase 227 (29.7%)
Phase 329 (31.9%)
Phase 412 (13.2%)
N/A11 (12.1%)

Trials by Status

withdrawn33%
recruiting66%
unknown1718%
active_not_recruiting88%
not_yet_recruiting33%
suspended11%
completed5557%
terminated33%

Recent Activity

Clinical Trials (96)

Showing 20 of 96 trialsScroll for more
NCT03819101Phase 3

Trial of Acetylsalicylic Acid and Atorvastatin in Patients With Castrate-resistant Prostate Cancer

Recruiting
NCT03654105Phase 2

Screening and Multiple Intervention on Lung Epidemics

Active Not Recruiting
NCT02647099Phase 3

Adjuvant Low Dose Aspirin in Colorectal Cancer

Active Not Recruiting
NCT05225961Phase 4

ATILA Project: Aspirin Versus Tirofiban in Endovascular Treatment for Patients With Acute Ischemic Stroke Due to Tandem Lesion

Active Not Recruiting
NCT03480776Phase 2

ASA in Prevention of Ovarian Cancer (STICs and STONEs)

Active Not Recruiting
NCT03463317Phase 4

Left Atrial Appendage CLOSURE in Patients With Atrial Fibrillation Compared to Medical Therapy

Completed
NCT02168829Phase 4

Optimal Anticoagulation for Higher Risk Patients Post-Catheter Ablation for Atrial Fibrillation Trial

Completed
NCT03326791Phase 2

Aspirin in Colorectal Cancer Liver Metastases

Active Not Recruiting
NCT06449469Not Applicable

The Nordic Aortic Valve Intervention Trial 4 (NOTION-4)

Active Not Recruiting
NCT02846532Phase 3

Pharmacokinetic, Pharmacodynamic, Safety, and Efficacy Study of Rivaroxaban for Thromboprophylaxis in Pediatric Participants 2 to 8 Years of Age After the Fontan Procedure

Completed
NCT04070573Phase 3

Low Doses of Aspirin in the Prevention of Preeclampsia

Completed
NCT03957902Phase 2

Assessment of Direct Biomarkers of Aspirin Action to Develop a Precision Chemoprevention Therapy of Colorectal Cancer

Recruiting
NCT05460416Phase 3

Treatment Preventive for Pre-eclampsia by Acetylsalicylic Acid in Women Who Underwent Frozen Embryo Transfer

Recruiting
NCT03245489Phase 1

Anti-platelet + Pembro for H&N Tumors

Completed
NCT05035316Phase 2

Effects of Low Dose Aspirin in Bipolar Disorder (The A-Bipolar RCT)

Completed
NCT03378297Early Phase 1

IMPACT: A Randomized WOO Study of Novel Therapeutic Agents in Women Triaged to Primary Surgery for EOC

Completed
NCT06277609Phase 1

A Trial Investigating Lu AF28996 in Healthy Adult Participants

Completed
NCT02046460Phase 3

Biomarkers and Antithrombotic Treatment in Cervical Artery Dissection - TREAT-CAD

Completed
NCT02984384Phase 3

PREVENTion of Clot in Orthopaedic Trauma

Completed
NCT03120182Not Applicable

Chronic Subdural Hematoma and Aspirin

Completed

Drug Details

Intervention Type
DRUG
Total Trials
96